conjugated estrogen

Animal productexperimental

Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications. It is a mixture of the sodium salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate. CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations. They are formulated both alone and in combination with progestins such as medroxyprogesterone acetate. CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle. — Wikipedia

Clinical trial activity

8 trials · 15 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
1

Earliest trial started Jul 31, 2019 (NCT03996603)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05073237Phase 2Jan 17, 2022Department of Veteran Affairs
NCT04821141Phase 2Dec 31, 2021National Cancer Institute (NCI), University of Kansas
NCT04821375Early Phase 1 (Phase 1)Dec 1, 2021University of Kansas
NCT05118685Phase 1Nov 13, 2021Fayoum University
NCT05464654N/AJun 23, 2021Hospital General Regional No. 1 IMSS, Hospital Regional 10 de Octubre, ISSSTE, Institut d'Investigacions Biomèdiques August Pi i Sunyer, National Autonomous University of Mexico, National Polytechnic Institute, Mexico, Regional Hospital October 1st
NCT04478305Phase 1Mar 31, 2021McMaster University, Pfizer, University of Western Ontario
NCT04379024Early Phase 1 (Phase 1)Jun 1, 2020Breast Cancer Research Foundation, University of Kansas
NCT03996603Phase 4Jul 31, 2019University of Alabama, Birmingham
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (15)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of KansasAcademic/Hospital3322020
Breast Cancer Research FoundationAcademic/Hospital1012020
Department of Veteran AffairsGovernment1112022
Fayoum UniversityAcademic/Hospital1112021
Hospital General Regional No. 1 IMSSAcademic/Hospital1012021
Hospital Regional 10 de Octubre, ISSSTEAcademic/Hospital1112021
Institut d'Investigacions Biomèdiques August Pi i SunyerAcademic/Hospital1012021
McMaster UniversityAcademic/Hospital1012021
National Autonomous University of MexicoAcademic/Hospital1012021
National Cancer Institute (NCI)Government1012021
National Polytechnic Institute, MexicoAcademic/Hospital1012021
PfizerFor profit1012021
Regional Hospital October 1stAcademic/Hospital1012021
University of Alabama, BirminghamAcademic/Hospital1112019
University of Western OntarioAcademic/Hospital1112021
15 organizations
Page 1 / 1